BKRKY yields 8.78% · JNJ yields 2.13%● Live data
📍 BKRKY pulled ahead of the other in Year 1
Combined, BKRKY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BKRKY + JNJ for your $10,000?
PT Bank Rakyat Indonesia (Persero) Tbk provides various banking products and services in Indonesia, Singapore, Timor Leste, Hong Kong, Taiwan, Singapore, and the United States. The company offers current and savings accounts; time deposits; house, micro business, working capital, investment, food, warehouse receipt, partnership, franchise, and cash collateral loans; and supply chain financing solutions. It also provides banking services, such as bill payment, deposit, online transaction, money transfer, and remittance services; investment products, such as pension and mutual funds, and retail bonds and retail sukuk products; import and export services; letter of credits; and BRI RTE online system and money changer services. In addition, the company offers Internet banking and merchant services; credit cards; wealth management services; business guarantee and clearing business services; financial and institutional business banking services; and treasury, custodian, trustee, and cash management services. PT Bank Rakyat Indonesia (Persero) Tbk was founded in 1895 and is headquartered in Jakarta, Indonesia.
Full BKRKY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.